Diabeloop

📍 Grenoble, France🗓 Founded 2015👥 159 employees💰 Last funded Jan 2022
Medical Equipment Manufacturing
LinkedIn
We want to provide people living with diabetes with an intelligent therapeutic system to regulate blood glucose. This project was initiated in 2011 by the CERITD (Centre d’Études et de Recherches pour l’Intensification du Traitement du Diabète) in collaboration with the CEA LETI. After the success of the clinical trials in 2014, we created Diabeloop to bring the project to market and make it available to the largest number of people. Since spring 2021, DBLG1 System, the first automated insulin delivery device, is being marketed in several European countries: Germany, Italy, Spain, Switzerland, the Netherlands and France.
4
Total investors
0
Early stage
3
Mid stage
1
Late stage
2015
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
4
Investor activity2019–2022 · investors recorded per year
201922020120221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Diabeloop?
Diabeloop has 4 investors on record on gritt.io, 3 mid-stage and 1 late-stage investors.
When did Diabeloop last raise funding?
The most recent investment in Diabeloop recorded on gritt.io was in January 2022.
When was Diabeloop founded?
Diabeloop was founded in 2015.
What industry is Diabeloop in?
Diabeloop operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Diabeloop based?
Diabeloop is headquartered in Grenoble, France.